SATURN V CAPITAL MANAGEMENT LP
Adviser information for SATURN V CAPITAL MANAGEMENT LP last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 4 |
---|---|
Investment Advisory/Research | 2 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 3 | $400.3M |
Non-Discretionary | 0 | $0 |
Total | 3 | $400.3M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $400.3M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 33 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
919 CONGRESS AVENUESUITE 830
AUSTIN
TX
United States
Monday - Friday, 9AM - 5PM
Tel: 415-738-4435, Fax: None
Chief Compliance Officer
DOUG EDWARDS
CFO
919 CONGRESS AVENUE
SUITE 830
AUSTIN
TX
United States
Tel:
415-738-4435
D*******@*****************M
(Full email address available in API data)
Regulatory Contact
XIAOYING TIAN
919 CONGRESS AVENUE
SUITE 830
AUSTIN
TX
United States
Tel:
415-738-4435
X****@*****************M
(Full email address available in API data)
Industry Affiliates
SATURN V CAPITAL GP LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
BLACKWELL PARTNERS LLC - SERIES A | Hedge Fund | $177.5M | $0.0M | 1 |
SATURN V CAPITAL LP | Hedge Fund | $222.7M | $1.0M | 32 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
TIAN, XIAOYING, (NMN) | Individual | – | LIMITED PARTNER | 09/2023 | > 75% |
EDWARDS, DOUGLAS, KEVIN | Individual | – | CHIEF COMPLIANCE OFFICER | 05/2023 | < 5% |
SVCM GP LLC | Domestic Entity | – | GENERAL PARTNER | 09/2023 | < 5% |
TIAN, XIAOYING, (NMN) | Individual | SVCM GP LLC | MANAGING MEMBER | 09/2023 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 8M | 628K | – |
AMICUS THERAPEUTICS INC | COM | 7M | 714K | – |
ANAPTYSBIO INC | COM | 6M | 250K | – |
ARGENX SE | SPONSORED ADR | 28M | 64K | – |
ASCENDIS PHARMA A/S | SPONSORED ADR | 15M | 113K | – |
BIOMARIN PHARMACEUTICAL INC | COM | 15M | 179K | – |
CARGO THERAPEUTICS INC | COM | 14M | 857K | – |
CELCUITY INC | COM | 12M | 761K | – |
COGENT BIOSCIENCES INC | COM | 14M | 2M | – |
CONTINEUM THERAPEUTICS INC | CL A | 1M | 73K | – |
CRINETICS PHARMACEUTICALS IN | COM | 21M | 480K | – |
CYTOKINETICS INC | COM NEW | 15M | 272K | – |
DISC MEDICINE INC | COM | 23M | 503K | – |
ENLIVEN THERAPEUTICS INC | COM | 4M | 152K | – |
INOZYME PHARMA INC | COM | 5M | 1M | – |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 7M | 1M | – |
ITEOS THERAPEUTICS INC | COM | 5M | 367K | – |
KALVISTA PHARMACEUTICALS INC | COM | 13M | 1M | – |
LONGBOARD PHARMACEUTICALS IN | COM | 2M | 71K | – |
MERUS N V | COM | 10M | 165K | – |
MORPHIC HLDG INC | COM | 2M | 48K | – |
NEUMORA THERAPEUTICS INC. | COM | 4M | 390K | – |
PHATHOM PHARMACEUTICALS INC | COM | 6M | 593K | – |
RAPPORT THERAPEUTICS INC | COM | 2M | 70K | – |
SYNDAX PHARMACEUTICALS INC | COM | 9M | 420K | – |
VAXCYTE INC | COM | 16M | 216K | – |